Mutation at the GLCI locus in Saccharomyces cerevisiae resulted in simultaneous deficiencies in glycogen and trehalose accumulation. 
Mutation at the GLCI locus in Saccharomyces cerevisiae resulted in simultaneous deficiencies in glycogen and trehalose accumulation. Extracts of yeast cells containing the glcl mutation exhibited an abnormally high trehalase activity. This elevated activity was associated with a defective cyclic AMP (cAMP)-dependent monocyclic cascade which, in normal cells, regulates trehalase activity by means of protein phosphorylation and dephosphorylation. Trehalase in extracts of normal cells was largely in a cryptic form which could be activated in vitro by ATP * Mg in the presence of cAMP. Normal extracts also exhibited a correlated cAMP-dependent protein kinase which catalyzed incorporation of label from [y-32P]ATP into protamine. In contrast, cAMP had little or no additional activating effect on trehalase or on protamine phosphorylation in extracts of glcl cells. Similar, unregulated activation of cryptic trehalase was also found in glycogendeficient strains bearing a second, independently isolated mutant allele, glcl-2. Since trehalase activity was not directly affected by cAMP, the results indicate that the gll mutation results in an abnormally active protein kinase which has lost its normal dependence on cAMP. Trehalase in extracts of either normal or mutant cells underwent conversion to a cryptic form in an Mg2+-dependent, fluoride-sensitive reaction. Rates of this reversible reduction of activity were similar in extracts of mutant and normal cells. This same, unregulated protein kinase would act on glycogen synthase, maintaining it in the phosphorylated lowactivity D-form. The glcl mutants provide a novel model system for investigating the in vivo metabolic functions of a specific, cAMP-dependent protein kinase.
The yeast reserve carbohydrate trehalose can be mobilized as an endogenous source of glucose under a variety of physiological conditions through action of the hydrolytic enzyme trehalase (EC 3.2.1.28) (11, 12, 15) .
A glycogen-deficient yeast mutant, bearing the gll gene, was shown by Rothman-Denes and Cabib (19) to prevent the in vivo conversion of low-activity D-glycogen synthase into the high-activity I-form (independent) of the enzyme. Although they considered the possibility that this defect might involve a protein kinaseprotein phosphatase, they were unable to demonstrate an abnormality in such a system (20) . In recent studies (1) it has been demonstrated that mutations at the GLCI locus result in simultaneous deficiencies in both glycogen and trehalose, which are inherited together, indicating that they have a common molecular basis. The present paper explores this relationship further and presents evidence indicating that both traits could be related to an abnormal protein kinase reaction which has lost its dependence on cyclic AMP (cAMP), as was suggested by preliminary results (14) .
Yeast cells contain two forms of the hydrolytic enzyme trehalase, a highly active form, trehalase-a, and an inactive "cryptic" form designated trehalase-c (26) . Cryptic trehalase appears to be converted to active trehalase by action of a cAMP-dependent protein kinase. Both trehalase-c and protein kinase activities have been partially purified (27) .
The present study demonstrates that the abnormally high trehalase activity associated with the glil mutation can be related to an elevated protein kinase activity which can incorporate label from [y-32PIATP into protamine. In ex-activity in mutant extracts. Evidence is also presented that active trehalase is converted to its cryptic form by a protein phosphatase present in extracts and that in normal Saccharomyces cerevisiae cells trehalase activity is regulated by a cAMP-dependent, monocyclic cascade system (3).
MATERIALS AND METHODS
Yeast cultures. The genotypes of the various strains used in this study are listed in Table 1 .
Growth conditions. Cells were grown in a medium containing 1% yeast extract-1% glucose. Cultures were grown in 400 ml of medium in 2-liter Erlenmeyer flasks, and incubation was at 28°C on a rotary shaker operated at 160 rpm. Harvested cells were washed twice with distilled water. Growth of cultures was followed by turbidity measurements at 570 nm. Glucose was determined with glucose oxidase (18) .
Trehalase preparation. Cells were grown in 1% yeast extract-1% glucose, harvested at the onset of diauxie, and washed twice in cold water. The cell pellet, containing 0.6 to 0.9 g (dry weight), was suspended in 4.0 ml of 0.1 M acetate buffer, pH 5.6, and disrupted in a Braun shaker with 5 g of glass beads (0.45-mm diameter) for two 1-min periods. The homogenate was centrifuged at 1,000 x g for 10 min. The resulting supernatant solution was centrifuged again at 10,000 x g for 25 min, and the precipitate was discarded. The supernatant fluid was cleared of metabolites by passage through a Sephadex G-25 column (1.0 by 20.0 cm) equilibrated with 0.05 M phosphate buffer, pH 7.5.
Activation of cryptic trehalase. To 0.4 ml of the column effluent, 0.1 ml of an activation mixture containing 4 mM ATP, 9 mM MgSO4, 50 p.M cAMP, 50 mM NaF, and 5 mM theophylline was added (27) . This mixture was prepared in 0.05 M phosphate buffer, pH 7.5. To the control, 0.1 ml of pure buffer was added. The reaction mixture was incubated at 30°C for 10 min and interrupted by adding 1.5 ml of 0.07 M maleate buffer, pH 6.0, containing 10 mM EDTA. The mixture was then centrifuged at 100,000 x g for 30 min to eliminate the microsomal fraction, and the supernatant solution was used for trehalase activity determination.
Trehalase activity determination. For GLC strains, 15 pLg of phenylmethylsulfonyl fluoride, and 100 ,ug of protamine (13) . When necessary, 10 ,uM cAMP was added. After incubation at 30°C for 10 min, the reaction was interrupted by addition of 10 p.l of a solution containing 10 mM ATP, 20 mM sodium pyrophosphate, and 50 mM sodium phosphate. Samples of 55 p1d were applied on Whatman 3 MM disks, soaked in 15% trichloroacetic acid for 15 min, and washed twice with 5% trichloroacetic acid. The samples were then immersed in 95% ethanol and dried at room temperature, and the radioactivity was determined in a scintillation counter.
Genetic analysis. Isolation of diploids, induction of sporulation, dissections, and tetrad analysis were performed as described by Hawthorne and Mortimer (9) and Sherman (21) . Maltose fermentation was indicated by indicator color change on agar medium containing 0.33% bromocresol purple. Glycogen synthesis in intact cells was indicated by direct staining of yeast colonies with a single drop of an iodine solution (0.4% KI, 0.2% I2). Normal cells stained brown, whereas deficient glcl cells acquired only a yellow shade after staining.
Special chemicals. Trehalose, theophylline, ATP, cAMP, NaF, protamine, phenylmethylsulfonyl fluoride and the enzymes for glucose determination were purchased from Sigma Chemical Co. Sephadex G-25 (superfine) was from Pharmacia Fine Chemicals, Inc.
[y-32PIATP was prepared according to Cashel et al. (2) . RESULTS The hypothesis that the glcl-l mutant contained an abnormally active trehalase (14) was tested by measuring trehalase activity in extracts prepared from the original isogenic strains, S288C and GS1-36, harvested near the onset of the diauxic transition phase. Trehalase activity in normal extracts could be increased severalfold by incubation with ATP Mg and cAMP, indicating that most of the enzyme was in a latent or cryptic form. In contrast, most of the trehalase activity in mutant extracts was already activated (Table 2) .
When the mutant allele was introduced into a normal wild-type strain, the highly active trehalase characteristic was inherited together with the deficiency in glycogen accumulation (strain BR15-7C).
An independently isolated glycogen-deficient mutant which contains a defective gene, allelic to glcl-I, has also been shown to be deficient in trehalose accumulation (4). The data in Table 2 Figure 1 shows that, even though total trehalase activity varies during growth, the extremely low proportion of trehalase-c in the mutant was a constant characteristic.
The low trehalase activity seen in the normal parental strain (S288C) can be increased dramatically by treatment with ATP Mg in the pres- (Table 3) . Therefore, although the extract from the parental strain does contain trehalase activity, most of the enzyme (81%) is in the inactive or cryptic state. Similar cAMPdependent activation could be seen in extracts of another normal strain, D311-3A. In that case cryptic trehalase was activated from 20.7 to 96.9 nmol of glucose minm mg of protein-.
In contrast, trehalase in extracts prepared from the glcl-l mutant is almost entirely in its active form irrespective of any additions. The data in Table 3 show that activation of the cryptic trehalase in extracts of the normal strain, S288C, requires both ATP and cAMP, whereas neither nucleotide causes an appreciable change in the trehalase activity obtained from cells of the glcl-l mutant. Apparently, then, the trehalase from the mutant is already almost completely activated. Table 4 shows that trehalase in both mutant (GS1-36) and normal (S288C) extracts can undergo a reversible, Mg2+-dependent, partial inactivation which is completely inhibited by 50 mM fluoride. Reactivation of trehalase by ATP Mg after its conversion to the cryptic form by Mg2+ is completely dependent on added cAMP in the extracts of normal cells, whereas a substantial reactivation of trehalase occurs in mutant extracts even in the absence of cAMP. These observations strongly suggest that the high trehalase activity of mutant extracts may result from an abnormally elevated cAMP-independent protein kinase activity which converts cryptic trehalase into the active, phosphorylated form. The high cAMP-independent phosphorylation seen in mutant extracts is indicative of an alteration in the regulatory capacity of the regulatory (R) subunit. Figure 2 shows that the rate of trehalase inactivation by a putative protein phosphatase is similar in mutant and normal extracts. Therefore, it is unlikely that the abnormally high trehalase activity in strain GS1-36 results from a defect in an inactivating enzyme (protein phosphatase). Direct measurements of protein phosphorylation in the two types of extracts were made with [-y-32P]ATP and protamine as substrates (Table  5) . Although both types of extract catalyzed substantial protamine phosphorylation, only the reaction catalyzed by an extract of normal cells was increased by adding cAMP. This result is indicative of the existence, in the mutant preparation, of an unusually active protein kinase with very limited sensitivity to cAMP. Figure 3 depicts the relationship between trehalase activity and the concentration of the protein kinase effector, cAMP. Activation by the parental cell extract is clearly sigmoidal. This behavior is presumed to indicate that cAMP acts as a positive effector in a forward, regulatory cascade (3) . Figure 4 shows that data calculated from the lower curve in Fig. 3 can be used to construct a linear sensitivity index plot (analogous to a Hill Incubation was at 30°C for 10 min.
dence of trehalase activation on ATP -Mg concentration. In the presence of cAMP, activation of trehalase in extracts of normal cells is almost completely dependent upon added ATP Mg, whereas the highly active trehalase of mutant cell extracts undergoes only a small additional activation by ATP -Mg. The concentration of ATP Mg required to attain maximum activation is very close to the physiological range of 1.5 ± 0.1 mM in yeast cells grown on glucose, as determined by Gancedo and Gancedo (7) . Since Mg2+ is probably present at nonlimiting concentrations in vivo, it could be expected that trehalase activities in mutant cells should be at or near the maximum value, as we observed.
The direct effect of cAMP in extracts of normal cells is confined to its action on the converter enzyme (the protein kinase). That it has no direct effect on the catalytic activity of trehalase is illustrated by the double-reciprocal plots depicted in Fig. 6 . The apparent Km for trehalose was determined for trehalase in normal extracts before and after activation (upper and lower curves, respectively). Although Vma, was increased threefold by addition of 10 ,M cAMP (in the presence of ATP -Mg), the value of Km was unchanged. Moreover, the Km of the enzyme in mutant extracts was also identical, indicating that the glil mutation has no detectable effect on trehalase itself, but only on its activation. The estimated mean (± standard error) of the Km calculated with a Sharp PC-1211 pocket computer was 5.62 x 10-3 ± 0.73 x 10-3 M.
DISCUSSION
The scheme in Fig. 7 presents a mechanism consistent with the observations presented in this and other studies. Investigations of yeast protein kinase by Takai et al. (25) and of the R subunit purified from S. cerevisiae (10, 23) indicate that this organism contains a cAMP-dependent enzyme with properties similar to protein kinase (type II) found in various animal tissues. The finding that the modulation system which regulates the reversible interconversion of cryptic and active trehalase has the properties of a monocyclic cascade (sensitivity index, 4.4) indicates that the cAMP-dependent converter enzyme, in extracts of the normal strain (S288C), acts directly on trehalase-c, a natural substrate. It is proposed that the gll mutation alters a subunit of this enzyme in such a way that the dissociation constant of the putative R2C2 complex is greatly increased. This could result from a structural change in the R subunit. Alternatively, the mutation could lead to deficiency in the amount of R produced relative to C. Irrespective of the molecular change caused by gll, there is, in fact, some residual effect of cAMP on the protein kinase activity of mutant extracts. In either case, the gll system provides a novel vehicle for investigation of protein kinase function both in vivo and in vitro.
The second regulatory component of the monocyclic system which modifies the interconvertible enzyme, trehalase, is most probably a protein phosphatase which is activated by Mg2+ ties (reduction of trehalase activity) similar to those found in normal extracts, it is unlikely that the trehalose accumulation deficiency can be attributed to an alteration in the reverse cascade, that is, to a noneffective inactivation of trehalase.
The pleiotropic nature of the gll phenotype served as an important clue in this investigation. in glucose medium, trehalose accumulation capacity increases (17) and substantial glycogen synthesis occurs (19) near the end of the logarithmic growth phase. Moreover, in normal strains both carbohydrates accumulate in nonproliferating cells incubated in glucose buffered with phosphate (17, 19) . It has been demonstrated (20) that the glcl-l mutation resulted in a deficiency in converting the low-activity D-form of glycogen synthase to the high-activity I-form of the enzyme. The authors also demonstrated an ATP-dependent I-to-D transformation and a Mg2+-stimulated D-to-I transforming activity in cell-free extracts. However, because they found these transforming activities in both mutant and normal extracts, and since they were unable to demonstrate a cAMP effect, they failed to reach a conclusion concerning the enzymatic defect associated with glcl.
The protein kinase responsible for the I-to-D transformation of yeast glycogen synthase may be a form of the cAMP-dependent enzyme described by Takai and colleagues (24, 25) . These investigators showed that their enzyme preparation could inactivate muscle glycogen synthase. Hixson and Krebs (10) purified the R subunit of a cAMP-dependent yeast protein kinase, using the proteinase inhibitor phenylmethylsulfonyl fluoride to minimize proteolytic effects. This protein is much larger than the analogous R subunit reported by Takai et al. (25) , who did not use proteolytic inhibitors.
It seems quite likely that the "activating factor protein" (27) which activates trehalase is the same cAMP-dependent protein kinase which transforms active glycogen synthase to its less active D-form. The simultaneous losses of both glycogen and trehalose accumulation resulting from independent gll mutations and the inheritance of these deficiencies, together with the lack of trehalase "crypticity," argue strongly that a single polypeptide, controlled by the nuclear gene GLC1, is involved in regulating both glycogen synthase and trehalase activity in vivo.
It is pertinent to note that the trehalase activating factor protein tended to lose dependence on cAMP during purification (27) . The authors did not use proteinase inhibitors. The failure to find cAMP effects on glycogen synthase I-to-D transformation (20) might have been caused by action of endogenous proteolytic enzymes on the R subunit of the native kinase.
Since the presence of a glil allele in any strain results in glycogen deficiency as well as in trehalose deficiency (1, 4) , it is apparent that the unregulated protein kinase described here is also acting on glycogen synthase, maintaining it in the low-activity D-form. It seems likely that, in yeasts, a single cAMP-dependent protein kinase acts as a converter enzyme for both the trehalase and the glycogen synthase cascades. However, since glycogen synthase from animal tissues contains multiple phosphorylation sites which can act as phosphate acceptors from different protein kinases in vitro (22), we cannot be completely certain that glycogen synthase is a "normal" physiological substrate of the trehalase phosphorylation kinase described in this study.
Notwithstanding the possibility of "misdirected" protein phosphorylation artifacts, the demonstration that the glil mutation is intimately associated with a protein kinase activity is a significant advance in the investigation of the physiological role of this important class of regulatory enzymes. An altered regulation of a cAMP-dependent protein kinase in a hepatoma cell line deficient in the activity of the cAMP binding protein has been described (8) . The results of 32p incorporation into histone, in the presence and absence of the cyclic nucleotide, when hepatocytes and hepatoma cells are compared are similar to those we report for the parental strain and the glcl mutant of S. cerevisiae. We have shown elsewhere (4) that mutations at the GLCI locus also result in a severe deficiency in synthesis of yeast catalase T. In this case, the protein kinase is implicated in regulating the actual synthesis of the enzyme rather than its activity. Conceivably, the translation of yeast catalase T is subject to hemedependent protein kinase action such as that which modulates eIF-2 in hemoglobin synthesis (5) . Moreover, it was demonstrated that cyclic nucleotide binding to the regulatory subunit of bakers' yeast protein kinase is prevented by heme (10) .
